Cargando…
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
Colorectal cancer (CRC) is one of the most fatal types of cancers that is seen in both men and women. CRC is the third most common type of cancer worldwide. Over the years, several drugs are developed for the treatment of CRC; however, patients with advanced CRC can be resistant to some drugs. P-gly...
Autores principales: | Beklen, Hande, Gulfidan, Gizem, Arga, Kazim Yalcin, Mardinoglu, Adil, Turanli, Beste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438820/ https://www.ncbi.nlm.nih.gov/pubmed/32903699 http://dx.doi.org/10.3389/fonc.2020.01273 |
Ejemplares similares
-
Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021) -
Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021) -
Pan-cancer mapping of differential protein-protein interactions
por: Gulfidan, Gizem, et al.
Publicado: (2020) -
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022) -
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
por: Kori, Medi, et al.
Publicado: (2023)